Sean McAllister

Summary

Affiliation: California Pacific Medical Center Research Institute
Country: USA

Publications

  1. ncbi Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells
    Sean D McAllister
    California Pacific Medical Center, Research Institute, 475 Brannan Street, San Francisco, CA 94107, USA
    Mol Cancer Ther 6:2921-7. 2007
  2. ncbi Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis
    Sean D McAllister
    California Pacific Medical Center, Research Institute, San Francisco, CA 94107, USA
    Breast Cancer Res Treat 129:37-47. 2011
  3. ncbi Cannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival
    Jahan P Marcu
    California Pacific Medical Center Research Institute, San Francisco, California 94107, USA
    Mol Cancer Ther 9:180-9. 2010
  4. ncbi Cannabinoids selectively inhibit proliferation and induce death of cultured human glioblastoma multiforme cells
    Sean D McAllister
    California Pacific Medical Center Research Institute, 475 Brannan St, Suite 220, San Francisco, CA 94107, USA
    J Neurooncol 74:31-40. 2005

Research Grants

  1. Cannabinoids Control Breast Cancer Progression Through Id-1
    Sean D McAllister; Fiscal Year: 2010

Collaborators

  • Pierre Yves Desprez
  • Garret L Yount
  • Jahan P Marcu
  • Darryl Lau
  • Dan H Moore
  • Jasmine Lee
  • Anne J Zielinski
  • Arash Pakdel
  • Rigel T Christian
  • Chandani Limbad
  • Maxx P Horowitz
  • Juanita Allison

Detail Information

Publications4

  1. ncbi Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells
    Sean D McAllister
    California Pacific Medical Center, Research Institute, 475 Brannan Street, San Francisco, CA 94107, USA
    Mol Cancer Ther 6:2921-7. 2007
    ..In conclusion, CBD represents the first nontoxic exogenous agent that can significantly decrease Id-1 expression in metastatic breast cancer cells leading to the down-regulation of tumor aggressiveness...
  2. ncbi Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis
    Sean D McAllister
    California Pacific Medical Center, Research Institute, San Francisco, CA 94107, USA
    Breast Cancer Res Treat 129:37-47. 2011
    ....
  3. ncbi Cannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival
    Jahan P Marcu
    California Pacific Medical Center Research Institute, San Francisco, California 94107, USA
    Mol Cancer Ther 9:180-9. 2010
    ..Our results suggest that the addition of cannabidiol to Delta(9)-THC may improve the overall effectiveness of Delta(9)-THC in the treatment of glioblastoma in cancer patients...
  4. ncbi Cannabinoids selectively inhibit proliferation and induce death of cultured human glioblastoma multiforme cells
    Sean D McAllister
    California Pacific Medical Center Research Institute, 475 Brannan St, Suite 220, San Francisco, CA 94107, USA
    J Neurooncol 74:31-40. 2005
    ..Evidence of selective efficacy with WIN 55,212-2 was also observed but the selectivity was less profound, and the synthetic agonist produced a greater disruption of normal cell morphology compared to Delta(9)-THC...

Research Grants3

  1. Cannabinoids Control Breast Cancer Progression Through Id-1
    Sean D McAllister; Fiscal Year: 2010
    ..This research could lead to new areas of investigation in the treatment of aggressive forms of breast cancer, which spread to other parts of the body, with novel cannabinoid compounds such as analogs of cannabidiol. ..